Salesforce (CRM) and Blue Shield of California have partnered to build an artificial intelligence-based system. They argue that this should make it easier for patients to get treatment approved through their insurance company, reducing the burden of weeks of prior authorization. Ideally late to same day process. The collaboration is expected to be announced this morning. The idea is not new, as some major insurance companies have worked on using AI to address claim approval or denial in the past. And now it faces significant headwinds amid concerns about increased denials, especially to older patients. Prior authorization is a decision-making…
Author: admin
Health care stocks fell last week after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the nation's top health agency. Vaccine makers like Moderna (MRNA) are down more than 5%, and big names like Pfizer PFE (PFE) are down about 2%. Some Wall Street analysts believe the slide is an overreaction, given that little is known about Kennedy's actual controversial policies and that he has not yet been confirmed by the U.S. Senate. Mr. Kennedy said it was too early to tell whether or how much of an impact it would have on the health sector. If confirmed…
President-elect Donald Trump's picks for the nation's top health agencies and their track records in office could fuel “anti-science” views and defund global public health efforts. There are concerns around the world. For example, at the beginning of the coronavirus pandemic, the Trump administration severed ties between the United States and the World Health Organization (WHO). Despite President Joe Biden restoring ties, subsequent struggles to obtain U.S.-made vaccines in low-income countries have left countries like Russia and China doing better than expected in responding to the global pandemic. It became possible to fulfill the role of President Trump has previously…
Like many industries preparing for Donald Trump's second term in office, the outlook for healthcare is mixed. However, headwinds such as tariffs and drug pricing are clearly blowing strongly. Analysts on the sidelines are also taking a wait-and-see approach. “Uncertainty surrounding policy changes is holding investors back, but potential administrative reforms under President Trump and related candidates are expected to continue in 2025,” analysts at Leerink Partners said in a December note. “We believe there will be more clarity through the appointment process early in the year.” The three key issues being watched are China, tariffs, and drug prices. China…
David Joyner, CEO of CVS (CVS), has ambitious plans to improve the company's retail healthcare business and create a more integrated system of health professionals. Joyner said his goal, telling Yahoo Finance, is that by leveraging what he considers a large labor pool, CVS will have a major impact on the health of the entire community he serves. “I'll see 30,000 pharmacists employed at CVS retail, pair it with one of the biggest labor forces of nurses around Minute Clinic and add Oak Street… doctors on top. “It's been a huge amount of care. Delivery model in this country,” he…
In the latest trading session, DaVita Healthcare (DVA) closed at $161.57, adjusting -0.01% from the previous day’s closing price. This stock price change lagged the S&P 500’s daily gain of 0.25%. Meanwhile, the Dow rose 0.2% and the tech-heavy Nasdaq added 0.56%.Heading into today, shares of the kidney dialysis provider had gained 4.41% over the past month, outpacing the Medical sector’s loss of 1.51% and the S&P 500’s gain of 1.65% in that time period.DaVita HealthCare’s upcoming earnings release will be of great interest to investors, as the company is expected to post EPS of $2.76, which would represent a…
In the latest trading session, DaVita HealthCare (DVA) closed at $159.07, adjusting -0.03% from previous closing price. The stock outperformed the S&P 500, which fell 0.17% on the day. Meanwhile, the Dow Jones Industrial Average fell 0.44%, and the tech-heavy Nasdaq fell 0.04%.Shares of the kidney dialysis provider have gained 5.11% over the past month, leading the Medical sector's decline of 3.8% and the S&P 500's gain of 1.25%.Analysts and investors alike will be keeping an eye on DaVita Healthcare's performance in its upcoming earnings release. The company's future EPS is expected to be $2.76, which would represent a -3.16%…
For immediate releaseChicago, IL – October 18, 2024 – Today, Zacks Equity Research will discuss UnitedHealth Group Inc. UNH, The Cigna Group CI, Humana Inc. HUM, and Molina Healthcare, Inc. MOH.Industry: HMOLink: https://www.zacks.com/commentary/2352108/4-hmo-stocks-to-watch-despite-continued-industry-headwindsThe U.S. health insurance industry, known as health maintenance organizations (“HMOs”), is expected to benefit from higher premiums from offering affordable health insurance plans, resulting in increased membership. Demand for Medicare is expected to increase as the U.S. population grows. age. Aggressive mergers and acquisitions (“M&A”) activity, supported by potential interest rate reductions, is contributing to the geographic expansion and diversification of HMOs.Investing in telemedicine platforms is important…
The healthcare services sector is undergoing a major evolution driven by innovation and digital applications. The growing demand for telemedicine has led to a significant increase in digital healthcare options over the past few years. The demand for digital healthcare treatments continues to increase in the form of online medical and AI-powered technology services with a focus on telemedicine, backed by the implementation of data and analytics.The global healthcare analytics market is expected to grow at a CAGR of 22.9% from 2024 to 2029, reaching over $130 billion by 2029, according to a recent report from Mordor Intelligence. Key stakeholders…
Chicago, IL – November 5, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in this blog include Healthcare Select Sector SPDR ETF XLV, Tenet Healthcare THC, Invesco Dynamic Building & Construction ETF PKB, and Dicom Industries DY. Highlights from Monday's analyst blog include: The U.S. economy added 12,000 jobs in October, CNBC cited, a sharp drop from September and less than the 100,000 jobs expected by the Dow Jones. The Boeing strike is estimated…